The European Rare Disease Models & Mechanisms Network (RDMM-Europe) has been established by Solve-RD – an EU-funded research project. The overall aim is to boost research in rare diseases, discover new disease-causing genes and obtain evidence for pathogenicity through functional validation.

For more information, visit the following website.

The European Rare Disease Models & Mechanisms Network (RDMM-Europe) has been established by Solve-RD – an EU-funded research project. The overall aim is to boost research in rare diseases, discover new disease-causing genes and obtain evidence for pathogenicity through functional validation.

For more information, visit the following website.

A call on research and innovation's actions will be launched on July 18, 2019. IMI projects aim at accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. The topics of this call are related to integrated research platforms, digital clinical trials, immune-mediated diseases, medicines safety, brain disorders, blockchain, antimicrobial resistance.

FInd more information on the following link.

The International Summer School on Rare Disease Registries and FAIRification of Data is a part of a series of training activities proposed by the European Joint Programme on Rare Diseases (EJP RD) which will take place at the Istituto Superiore di Sanità, Rome, Italy. The first module “Rare Disease Registries” starts on September 23 till September 25, 2019. The second module “FAIRification of data”, starts on September 26 till September 27, 2019.

Onlne registration deadline is June 20th, 2019.

Find more information on the following link.

The European Joint Programme on Rare Diseases (EJP RD), which is the successor of E-Rare launches the Joint Transnational Call 2019. The call will  open officially in December. This year projects should focus on accelerated diagnosis and/or exploration of disease progression and mechanisms of rare diseases. More info under www.ejprarediseases.org

2016 RE(ACT) Congress

Having trouble reading this e-mail ? View it in your browser
ERA-Net for Research Programmes on Rare Diseases
2016 RE(ACT) Congress

The 3rd edition of the RE(ACT) Congress – International Congress on Research of Rare and Orphan Diseases will be held from 9th to 12th March 2016 at the Crowne Plaza Barcelona – Fira Center in Barcelona, Spain. This congress is jointly organized by the Blackswan Foundation and E-Rare.

Preferential prices are available for
-    RE(ACT) community members (Free sign-up for the RE(ACT) Community here): 300€
-    E-Rare Granted researchers: 300€
-    Post-graduate trainees (MSc./PhD Students, research students): 200€
-    Students: 150€
-    Patients organizations: 200€.
You can profit from those special prices until the 18th of January : REGISTER NOW!!

The conference sessions will explore issues and cutting-edge technologies that affect many adult and pediatric conditions on the following topics :
-    Drug repositioning and personalized medicine
-    NGS and undiagnosed rare diseases
-    Pathophysiology
-    Bringing treatments to the clinic
-    Neurological diseases
-    Patients and research
The full program is now available.

The congress will bring together world leaders and young scientists from stem cell, cell biology, gene therapy, human genetic, or therapeutic applications to present state-of-the-art research, to discuss results and to exchange ideas. Moreover, many patients and patient organization, which are committed in research, will be present to share their experience.


Before the official start of the RE(ACT) meeting, E-Rare will organize in collaboration with EMA a workshop dedicated to Interactions between EMA and RD researchers on pre-licensing activities. The workshop will take place from 09:00 to 13:00 on the 9 of March 2015 in Barcelona. It will be open to all researchers and interested stakeholders.

The program will include 4 sessions:
- Pre-licensing activities of EMA with the presentation of relevant EMA services (COMP, SAWP, PDCO, CAT)
- Orphan designation and incentives for researchers including information on how to submit OD and Protocol assistance – how it works
- Lessons learnt from Horizon 2020 success stories on obtaining an OD
In addition, a face-to-face meetings with EMA officers session, dedicated to researchers that already prepared a draft submission package for OD or protocol assistance, will be organised in the afternoon (14:00 to 16:00).
 
The places for Face-to-face meetings with EMA officers are limited! If you would like to participate, please send an email to juliane.halftermeyer[at]agencerecherche.fr where you will get more instructions.

www.e-rare.eu contact@erare.eu

E-Rare 2012 - Created by Toussaint Biger